CLB
Core Laboratories Inc. /DE/
NYSE · Energy · Oil & Gas Equipment & Services · NL
$10.00
+2.25%Year over year
Reported trailing growth
- Revenue
- +0.3%
- EBITDA
- -8.4%
- EBIT
- -10.5%
- EPS
- -10.6%
- Free cash flow
- -72.7%
- Operating cash flow
- -48.0%
Forward estimates
Based on analyst estimates
- Revenue
- +0.8%
- EBITDA
- +20.4%
- EPS
- +28.4%
Three-year CAGR
- Revenue
- +2.4%
- EBITDA
- +6.6%
- EBIT
- +6.7%
- Net income
- +15.1%
- EPS
- +17.4%
- Free cash flow
- +14.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026